FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Apollo Care Semaglutide 6 Recall

SEMAGLUTIDE 6

Apollo Care, LLC · Columbia, MO

Risk level
Class II
Reported by FDA
Aug 19, 2026
Recall ID
D-0749-2026
Check your lot numberHow we source this data

Summary

Apollo Care recalled Semaglutide 6 starting Jul 29, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0749-2026 on Aug 19, 2026. Reason: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material. Status: Ongoing.

Why it was recalled

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Product description

SEMAGLUTIDE 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202 NDC 71170-821-01

Lot numbers, UPCs & expiration codes

Lot: C-017115, Exp. 11/25/2026; AC-017163, Exp. 12/31/2026; AC-017169, AC-017170, AC-017171, Exp. 12/31/2026; AC-017230, AC-017231, Exp. 5/5/2027.

Where it was sold

Nationwide within the U.S

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0749-2026
Classification
Class II
Status
Ongoing
Recall initiated
Jul 29, 2026
FDA report date
Aug 19, 2026
Quantity
37,546 vials.
Recall type
Voluntary: Firm initiated
Recalling firm
Apollo Care, LLC

Original FDA data

Every field from FDA enforcement report D-0749-2026, exactly as published.

Show all FDA fields
City
Columbia
State
MO
Status
Ongoing
Country
United States
Event ID
99505
Address
3801 Mojave Ct Ste 101
Code information
Lot: C-017115, Exp. 11/25/2026; AC-017163, Exp. 12/31/2026; AC-017169, AC-017170, AC-017171, Exp. 12/31/2026; AC-017230, AC-017231, Exp. 5/5/2027.
Postal code
65202-4042
Report date
Aug 19, 2026
Product type
Drugs
Recall number
D-0749-2026
Classification
Class II
Recalling firm
Apollo Care, LLC
Product quantity
37,546 vials.
Reason for recall
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Voluntary / mandated
Voluntary: Firm initiated
Product description
SEMAGLUTIDE 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202 NDC 71170-821-01
Distribution pattern
Nationwide within the U.S
Recall initiation date
Jul 29, 2026
Initial firm notification
E-Mail
Center classification date
Aug 7, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0749-2026, published Aug 19, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls